Theorem Names Biopharma VP

Connie Wierman has been named vice president of biopharmaceutical development for Theorem Clinical Research. She will lead the company’s oncology therapeutic focus.
 
Ms. Wierman has more than 25 years of biopharma experience. She has held a number of executive positions at leading firms, including vice president of clinical development in oncology for INC Research. She was also responsible for developing and leading a medical team in 12 territories across the U.S. for ILEX (now Sanofi-Aventis) to support the research for oncology products.
 
“We’re building a team of top industry professionals at all levels of the Theorem organization and Connie fits right into that vision,” said Theorem president and chief executive officer John Potthoff. “She has built an impressive career with an emphasis on the global clinical development of oncology therapies. We count on her to provide an excellent operational environment and successful outcomes for our clients.”